Latest Strategy News

Haranga Resources reports progress in its uranium and gold projects in Senegal, securing $500,000 in convertible loan funding to support upcoming drilling programs and exploration activities.

DXN Limited reported a robust 58.1% revenue increase to $4.8 million in Q2 FY25, underpinned by strategic capital raising and new product innovation targeting AI infrastructure. The company is advancing key mining and telecom projects while streamlining operations to support its ambitious $16 million revenue guidance for FY25.

Paradigm Biopharmaceuticals has secured FDA clearance for its phase 3 knee osteoarthritis trial and raised $16 million to fund its next clinical steps, positioning the company for a pivotal year ahead.

Impact Minerals Limited reported its December 2024 quarterly cash flow, revealing ongoing exploration expenditures and a significant $2.87 million grant to commercialise its High Purity Alumina process at Lake Hope.

Firebird Metals Limited has secured preliminary design approval for its battery-grade manganese sulphate plant in China and forged a strategic partnership to develop LMFP cathode materials, marking significant progress in its EV battery ambitions.

NH3 Clean Energy has made significant strides in its WAH2 Project, finalising critical commercial agreements and progressing technical work ahead of Front End Engineering and Design (FEED) entry scheduled for Q1 2025. The company also completed a capital raise to support these developments.

Carbine Resources reports steady progress on its Muchea West silica sand mining licence application, engaging environmental consultants to support upcoming approvals. The company also continues exploration efforts at its Down South project.

Enova Mining has completed a significant drilling campaign at its CODA North project, confirming high-grade rare earth element mineralisation, while securing $1.5 million in new funding to accelerate exploration and metallurgical testing.

Zelira Therapeutics has secured a fourth funding tranche of US$681,000, advancing its HOPE® Autism Spectrum Disorder FDA trial process and bringing total funding to US$3.25 million. The company is progressing clinical validation and product development, including the transformation of Zenivol® into a capsule formulation.

Echo IQ Limited has secured FDA clearance for its EchoSolv AS technology and appointed a US-based CEO, marking a pivotal shift towards commercialisation in the American healthcare market.

Tyranna Resources has completed a key drilling phase at its Namibe Lithium Project in Angola, intersecting visible spodumene and expanding its exploration footprint. The company also lodged its first license application as it pursues a broader strategy targeting demand-driven metals.

Traka Resources reports steady progress in its December 2024 quarter, focusing on exploration at Gorge Creek and Cranbrook while withdrawing from Mozambique projects to sharpen its strategic focus.